Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Jabryus 50mg Tablet
Manufacturer/Marketed By : GLENMARK PHARMACEUTICALS LTD
$439.25 $379.35
Jabryus 50mg Tablet contains an active ingredient known as Abrocitinib that belongs to a class of Janus kinase inhibitors. It is used to improve skin conditions and reduce itchiness. It...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ABROCITINIB
Active Pharmaceutical Ingredient
Jabryus 50mg Tablet
439.25$
379.35$
Jabryus 50mg Tablet contains an active ingredient known as Abrocitinib that belongs to a class of Janus kinase inhibitors. It is used to improve skin conditions and reduce itchiness. It helps to improve sleep disturbance due to itchiness and overall quality of life. It aids in improving the symptoms of anxiety and depression associated with atopic dermatitis. Jabryus 50mg Tablet is used to treat patients with moderate-to-severe atopic dermatitis or atopic eczema, a chronic skin disease. Inform your doctor if you're allergic to Abrocitinib, lactose, or any of the ingredients present in the medicine. Consult your doctor if you have a serious infection (tuberculosis) or severe liver problem before using the medicine. It is recommended that you inform your doctor if you are using any immunosuppressant or any other medicine. Inform your doctor if you have a plan to vaccinate or have been recently vaccinated. Consult your doctor if you have a blood clot in the vein of the legs or lungs, a heart problem, or cancer. Your doctor may advise you to do a blood test. The safety and efficacy of the medicine in children below 12 years of age have not been established. Inform your doctor if you are a patient who is at the age of 65 years or above, it may increase the risk of infection, heart attack and certain types of cancer in such patients.
Active Pharmaceutical Ingredient
Uses
• Treat moderate-to-severe atopic dermatitis in adults
Benefits
Jabryus 50mg Tablet is a Janus kinase inhibitor that helps to reduce the activity of the enzyme Janus kinase, which is involved in inflammation. Therefore, it helps to improve the skin condition related to atopic dermatitis in patients.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Common Side Effects
• Feeling sick in the stomach (nausea)
• Cold sores
• Vomiting
• Upper abdominal pain
• Dizziness
• Acne
• Increase the blood creatine phosphokinase enzyme level.
How To Use
Always use this medicine as exactly prescribed by your doctor. Depending on the condition being treated, your physician decides the dose, dosage, and frequency of this medicine. Do not chew, crush or dissolve the tablets. Swallow the tablets whole with water.
Safety Advice
• Breast Feeding: It is unknown whether Jabryus 50mg Tablet is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Consult your doctor for more information.
• Alcohol: It is unknown whether consuming alcohol while taking a Jabryus 50mg Tablet is safe. Please speak with your physician before using the medicine.
• Liver: Inform your physician about any underlying liver disorders before taking Jabryus 50mg Tablet, as this medicine may not be given to patients who have a severe liver disorder.
• Lungs: It is unknown whether the Jabryus 50mg Tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: It is unknown whether Jabryus 50mg Tablet alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
• Pregnancy: It is unknown whether the Jabryus 50mg Tablet is harmful to the unborn baby. Notify your healthcare professional if you are pregnant, planning to have a baby or think you might be pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.